All In Biotech

Free tool

FAERS Monitor: Pylarify

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214793 or its brand name (Pylarify, Piflufolastat F-18). Reports on generic versions are filed under their own applications.

Reports

334

Serious

14

4% of reports

Hospitalization

4

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • radioisotope scan abnormal104
  • drug ineffective75
  • product dispensing error36
  • product dose omission issue32
  • underdose30
  • product dispensing issue29
  • intercepted product administration error26
  • intercepted product dispensing error22
  • product preparation error15
  • occupational exposure to radiation8
  • wrong product administered8
  • dizziness7
  • fatigue7
  • product contamination7
  • product administration error6

Reports by year received

View as table
YearReports
20216
202231
202355
202424
202578
2026140

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,825 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
occupational exposure to radiationSignal818677.28547.6101,295
radioisotope scan abnormalSignal10410871.89095.9954,949
intercepted product dispensing errorSignal22847.1564.017,523
product dispensing issueSignal29429.8303.211,903
intercepted product administration errorSignal26214.3148.05,292
product contaminationSignal7124.159.6735
product dispensing errorSignal36104.376.63,577
wrong product administeredSignal874.737.6510
product preparation errorSignal1546.028.1616
underdoseSignal3025.918.4695
product administration errorSignal618.78.584
product dose omission issueSignal326.94.9156
drug ineffectiveSignal753.62.9146
dizziness70.90.40
fatigue70.60.32

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.